EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gram‐Scale Synthesis of an Arylsulfonamide‐Type Alkaline Phosphatase Inhibitor

Zsolt Rapi iD, Krisztina Fülöp iD, Zoltán Mucsi iD

ChemMedChem · 25.02.2026 · 21 (4)

DOI: 10.1002/cmdc.202500328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 25.02.2026. Verfasst von Zsolt Rapi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology Budapest University of Technology and Economics, Bud…. Hauptthemen laut MEDLINE: Alkaline Phosphatase, Enzyme Inhibitors, Sulfonamides. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nemzeti Kutatási Fejlesztési és Innovációs Hivatal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alkaline phosphatases (ALP) are present in most living organisms. This family of metalloenzymes catalyzes transphosphorylation reactions and hydrolyzes phosphate monoesters. ALP enzymes have significant roles in several physiological processes and disease states. Inhibition of these enzymes makes it possible to prevent or treat certain diseases, and their role in normal physiology can also be examined. Several inhibitors with diverse chemical structures have been reported. One of them, known as SBI‐425, has a low IC 50 value (16 nM). An alternative, scalable method was established to prepare SBI‐425 in larger amounts for in vivo experiments. In three simple steps, 4‐chloroanisole was transformed to the appropriate sulfonyl chloride, which was used to acylate 3‐aminonicotinamide. Without the need for chromatography or crystallization, the desired inhibitor was obtained with >90% purity (based on UPLC‐MS analysis). The synthesis could also be carried out on a 10‐fold scale, with identical outcomes. The final product was subjected to biological testing, and it was found to be effective in inhibiting ALP activity in mouse serum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alkaline PhosphataseEnzyme InhibitorsSulfonamidesAnimalsMiceMolecular StructureStructure-Activity RelationshipDose-Response Relationship, Drug

Stichwörter der Autor:innen

alkaline phosphataseinhibitorscalabilitysynthesis

Substanzen

Alkaline PhosphataseEnzyme InhibitorsSulfonamides

Autor:innen und Institutionen

  • Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology Budapest University of Technology and Economics, Budapest, Hungary.
  • BrainVisionCenter Ltd., Budapest, Hungary.
  • Institute of Molecular Life Sciences, Research Centre for Natural Sciences, Hungarian Research Network, Budapest, Hungary.
  • Femtonics Ltd., Budapest, Hungary.

ORCID-Profile: Zsolt Rapi, Krisztina Fülöp, Zoltán Mucsi

Förderung

  • Nemzeti Kutatási Fejlesztési és Innovációs Hivatal

Zitieren

APA

Rapi, Z., Fülöp, K., & Mucsi, Z. (2026). Gram‐Scale Synthesis of an Arylsulfonamide‐Type Alkaline Phosphatase Inhibitor. ChemMedChem, 21(4). https://doi.org/10.1002/cmdc.202500328

Vancouver

Rapi Z, Fülöp K, Mucsi Z. Gram‐Scale Synthesis of an Arylsulfonamide‐Type Alkaline Phosphatase Inhibitor. ChemMedChem. 2026;21(4). doi:10.1002/cmdc.202500328

BibTeX
@article{Rapi2026,
  author = {Rapi, Zsolt and Fülöp, Krisztina and Mucsi, Zoltán},
  title = {Gram‐Scale Synthesis of an Arylsulfonamide‐Type Alkaline Phosphatase Inhibitor},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {4},
  doi = {10.1002/cmdc.202500328}
}
Kostenlos starten →